AJP - Renal Physiology, Vol 266, Issue 6 858-F867, Copyright © 1994 by American Physiological Society

ARTICLES

Endogenous renal dopamine production regulates phosphate excretion

A. Debska-Slizien, P. Ho, R. Drangova and A. D. Baines
Department of Clinical Biochemistry, University of Toronto, Ontario, Canada.

We examined the effect of endogenous dopamine production on Pi and citrate excretion by Wistar rats. Carbidopa (20-40 mumol/kg ip) decreased dopamine, Pi, and citrate excretion within 20 min (86%, 47%, and 38%, respectively); Pi reabsorption increased 11 +/- 4% (P = 0.03). The decreases were sustained for at least 18 h. 3-Hydroxybenzylhydrazine (45 mumol/kg ip) reduced Pi excretion 24%. Benserazide (40 mumol/kg ip and 0.1 mumol/min iv) reduced dopamine excretion (94%) and blocked the effect of carbidopa on Pi and citrate excretion. In isolated perfused kidneys benserazide, carbidopa, and 3-hydroxybenzylhydrazine all decreased Pi excretion. Dopamine (1 mumol/l) added to cortical minceates reduced brush-border membrane vesicle (BBMV) 32P uptake by 8% (P < 0.02) and amiloride-inhibitable 22Na uptake by 19%. Carbidopa added to minceates increased 32P uptake by 12%. Carbidopa pretreatment increased (75%) amiloride-sensitive 22Na uptake into BBMV of rats fed a high-salt diet. Uptake was not increased into BBMV from rats fed a low-salt diet. Carbidopa increased (17%) basolateral membrane Na(+)-K(+)-adenosinetriphosphatase (Na(+)-K(+)-ATPase) gradually over 4 h. Na(+)-K(+)-ATPase did not increase in rats fed a low-phosphorous diet, but did increase when dopa was added to the diet. Thus endogenous dopamine appears to directly control Na(+)-Pi and Na+/H+ transport and secondarily alter basolateral membrane Na(+)-K(+)-ATPase.

This article has been cited by other articles:

				D. Bacic, P. Capuano, M. Baum, J. Zhang, G. Stange, J. Biber, B. Kaissling, O. W. Moe, C. A. Wagner, and H. Murer Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells Am J Physiol Renal Physiol, April 1, 2005; 288(4): F740 - F747. [Abstract] [Full Text] [PDF]

				P. Gomes, M. A. Vieira-Coelho, and P. Soares-da-Silva Ouabain-insensitive acidification by dopamine in renal OK cells: primary control of the Na+/H+ exchanger Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R10 - R18. [Abstract] [Full Text] [PDF]

				Y. Wang, T. J. Berndt, J. M. Gross, M. A. Peterson, M. J. So, and F. G. Knox Effect of inhibition of MAO and COMT on intrarenal dopamine and serotonin and on renal function Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R248 - R254. [Abstract] [Full Text] [PDF]

				J. M. GROSS, T. J. BERNDT, and F. G. KNOX Effect of Serotonin Receptor Antagonist on Phosphate Excretion J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1002 - 1007. [Abstract] [Full Text]

				F. E. Albrecht, J. Xu, O. W. Moe, U. Hopfer, W. F. Simonds, J. Orlowski, and P. A. Jose Regulation of NHE3 activity by G protein subunits in renal brush-border membranes Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2000; 278(4): R1064 - R1073. [Abstract] [Full Text] [PDF]

				N. H. Garcia, T. J. Berndt, G. M. Tyce, and F. G. Knox Chronic oral L-DOPA increases dopamine and decreases serotonin excretions Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1999; 277(5): R1476 - R1480. [Abstract] [Full Text] [PDF]

				C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON Dopamine Receptors: From Structure to Function Physiol Rev, January 1, 1998; 78(1): 189 - 225. [Abstract] [Full Text] [PDF]